Femtosecond Laser Arcuate Incisions

Planning the incisions
To determine the depth of the incision and appropriate treatment pattern, we obtain central pachymetry measurements in all four quadrants at the time of surgery. The thinnest quadrant – often the lower temporal quadrant – is selected. We identify an optical zone that is large enough for the procedure, approximately 6.0mm, and then set the laser for the appropriate depth. We use a surgical topography system (Keratron Scout, Optikon) to precisely determine the axis of astigmatism at the time of surgery. The arcuate cuts are made on the steep axis, with the procedure lasting nine to 12 seconds. Treatment is confined strictly within the stroma, eliminating danger of infection, wound gape or epithelial ingrowth because one doesn’t cut through Bowman’s. We can customise results for each patient by producing different treatment patterns based on optical zone diameter, incision depth and the angle of the cuts (Figure 1). Four angled incision patterns between 30° and 150° were identified for study. We selected patterns for individual patients based on factors such as amount of astigmatism, corneal thickness, age and pupil diameter. The larger the optical zone diameter and inclination angle with a given anterior diameter, the smaller the correcting effect.Study results
So far, our femtosecond laser arcuate incisions for correction of low astigmatism have produced very safe, precise and predictable results. During initial treatments, we identified an optimal treatment pattern with a constant arc length, inclination angle and changes in incision depth that were based on corneal thickness. This pattern was applied to 10 eyes, followed for three to six months (mean of 4.9 months), upon which we base our early results: n Mean UCVA improved from 20/50 pre-op to 20/32 post-op; n 81.8 per cent of subjects gained at least one line of UCVA, 19.2 per cent were stable, and no one lost a Snellen line of UCVA; n Average reduction of keratometric astigmatism was 58.7 per cent (Figure 2). In the study, all incisions were on target and no perforations occurred. In one case, suction was lost during surgery, but the procedure was completed successfully. Patient satisfaction also has been high because the procedure can be done quickly and with minimal discomfort. Compared to bladed incisions, intrastromal laser incisions appear to be safer, enabling us to preserve the corneal surface, including Bowman’s membrane and the epithelium. We look forward to acquiring more data with the recent initiation of a larger trial involving about 125 eyes at our centre and three others in Europe. As the numbers of patients undergoing these treatments increase, we anticipate development of more accurate nomograms that incorporate new incision patterns and additional factors such as age and gender to improve results. We would also like to explore the addition of concentric incisions to increase effect for higher degrees of astigmatism. Prof Grabner is professor of ophthalmology and chairman of the University Eye Clinic at Paracelsus Medical University in Salzburg, Austria. Contact him at: G.Grabner@salk.atÂLatest Articles
Simulators Benefit Surgeons and Patients
Helping young surgeons build confidence and expertise.
Making Female Leadership More than a Moment
A remarkable global confluence of women in key positions.
ESCRS Talks Technology at AAO
Europe adopts technological advances, US still waiting for lenses and lasers.
Sorting Out Simultaneous Vision IOLs
The ESCRS Eye Journal Club discuss a new landmark paper on IOL classification and the need for harmonisation of terminology for presbyopic IOLs.
Big Advantages to Small-Aperture IOLs
Small-aperture IOLs offer superior image quality with increased range of focus.
Prioritising Self-Care
Benefits of maintaining physical, emotional, and mental health extend beyond the personal sphere.
Valuing Clinical Trial Design
How inclusivity and diversity can enhance scientific accuracy in research.
Knowing Iris Repair: Using Iridodiathermy in Iris Surgery
Prepare for decentred pupils and uneven irides in multiple situations.
Neuroprotectant Treatment for MacTel Type 2
Intravitreal implant releasing ciliary neurotrophic factor found safe and effective in pivotal trials.